While Ozempic (semaglutide) is widely known for its role in managing type 2 diabetes and promoting weight loss, recently researchers have begun to explore Ozempic for substance abuse and addiction treatment.
Though human studies on this topic are still limited, the growing body of anecdotal evidence suggests that Ozempic may offer hope for those struggling with addiction.
Research is still ongoing, but if studies continue to show results, it may offer a new avenue for recovery.
Benefits of Ozempic besides weight loss
While it has recently become more well known for weight loss, it was originally developed as a type 2 diabetes medication. So, it also helps to control blood sugar.
But the benefits don’t stop there. Research has uncovered several unexpected benefits of Ozempic.
Unexpected benefits of Ozempic
While Ozempic is primarily known for weight loss and blood sugar control, it also offers several other health benefits:
-
- Lowers blood pressure: Ozempic has been shown to help reduce high blood pressure.
- Improves lipid profiles and fatty liver disease: It can help improve cholesterol levels and reduce liver fat, benefiting those with fatty liver disease.
- Reduces the risk of heart and kidney disease: Ozempic has been found to lower the risk of heart disease and kidney complications in people with type 2 diabetes.
- Improves cardiovascular outcomes: Wegovy (which contains the same active ingredient as Ozempic) is now FDA-approved to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and obesity or overweight.
Ozempic has also recently been studied for its potential to help treat substance abuse.
Recent findings on Ozempic and substance abuse
Recent studies have shown promising results in using Ozempic for substance abuse. While clinical studies in humans have not yet been completed, preclinical trials are showing encouraging results:
- Rodent Studies:
- Research conducted by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and The Scripps Research Institute found that semaglutide reduced alcohol consumption and binge-like drinking in rodents.
- Research conducted by Penn State found that Ozempic and similar medications reduced relapse to heroin and fentanyl seeking in male and female rats.
- Preliminary Human Findings:
- In a small, unpublished study, individuals who were given semaglutide experienced a reduction in heavy drinking and drinking quantity compared to those in the placebo group.
- One study found those on Ozempic or similar medications had a 50% lower rate of binge drinking compared to those not on the medication. Those with opioid use disorder who were prescribed Ozempic had a 40% lower rate of opioid overdose.
- A trial at Caron Treatment Centers conducted by Penn State found a 40% reduction in opioid cravings among participants taking the GLP-1 drug liraglutide compared to those receiving a placebo.
There are also plenty of anecdotal reports that Ozempic also helps reduce cravings for other substances, such as nicotine, alcohol, and even compulsive behaviors like gambling and skin picking.
Why Ozempic may work for tackling substance abuse?
Scientists are still working to understand exactly how Ozempic (semaglutide) and similar medications help with substance abuse. Kyle Simmons, director of Oklahoma State University’s Biomedical Imaging Center, is leading one of several clinical trials examining whether semaglutide can reduce alcohol cravings. He suggests that the drug affects the brain by diminishing the pleasure associated with drinking alcohol.
Dr. Lorenzo Leggio, clinical director at the National Institute on Drug Abuse, explains that the brain mechanisms involved in food-seeking behaviors overlap with those related to addiction. Ozempic works by targeting a hormone that signals fullness, and through mechanisms not yet fully understood, it weakens the brain’s connection between food and pleasure, which may extend to other addictive behaviors.
Ozempic mental health benefits
Research shows that one in four adults with serious mental health problems will also have a substance abuse problem. Certain mental health problems—like depression and anxiety disorders—can increase the chance of developing a substance abuse problem.
While Ozempic and other GLP-1 medications do not treat depression or anxiety, there is a chance they may help prevent it. A study by Epic Research found that those taking semaglutide were 45% less likely to receive a new depression diagnosis, and 44% less likely to be diagnosed with an anxiety disorder.
Taking Ozempic for substance abuse recovery
Ozempic is not yet approved specifically for treating substance abuse. But clinical trials are still ongoing and positive early findings suggest that this may change in the future.
If you’re interested in using Ozempic for weight loss, Heally can help. Schedule a consultation with Heally today to discuss how Ozempic can support your goals.
Sources
- National Institute on Alcohol Abuse and Alcoholism: Semaglutide shows promise as a potential alcohol use disorder medication
- CBS News: Unexpected side effect from popular weight loss drugs studied for help with addiction treatment
- UNC Health: Clinical Trial on Semaglutide Shows Promise for Treatment of Alcohol Use Disorder, Warrants Further Trials
- NPR: Ozempic shows promise for alcohol and drug addiction, study finds
- Penn State Health News: Q&A: Can weight loss drugs help in addiction treatment?
- Scientific American: Could New Weight-Loss Drugs like Ozempic Treat Addiction?
- WebMD: Do Ozempic, Other Obesity Meds Have Extra Health Benefits?
- Healthline: 5 Ways Ozempic, Wegovy, and Other Weight Loss Drugs May Improve Your Health
- Substance Abuse and Mental Health Services Administration (SAMHSA): Mental Health and Substance Use Co-Occurring Disorders
- Epic Research: Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses